Skip to search formSkip to main contentSkip to account menu

batracylin

Known as: 8-Aminoisoindolo(1,2-b)quinazolin-12(10H)-one, 8-aminoisoindolo(1,2-b)quinazolin-12(10H)one, DANIQUIDONE 
A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND Batracylin is a heterocyclic arylamine topoisomerase inhibitor with preclinical anticancer activity. Marked species… 
2014
2014
A convenient procedure for the carbonylative synthesis of isoindoloquinazolinones has been developed. Using 1,2-dibromobenzenes… 
2007
2007
A172 Batracylin (8-aminoisoindolo [1,2-b]quinazolin-10(12H)-one; NSC320846) is an investigational clinical anticancer agent… 
2004
2004
SummarySince 1978, over 50 clinically useful antitumor drugs or new candidate antitumor agents have been evaluated in vivo… 
2004
2004
The heterocyclic amine, batracylin (BAT), is genotoxic and several lines of evidence suggest that acetylation is one step in the… 
1993
1993
A number of isoindolo[1,2-b]quinazolines and some benzo[4,5]isoquinolino[1,2-b]quinazolines as structural modification analogues… 
1988
1988
The antitumour efficacy of batracylin was investigated in vivo against murine tumours. The drug displayed an original spectrum of…